SEARCH  web site
COMPANIES
Discover the reality of companies and brands !
List by name, country, industry, manager, or updated this month, by topic:
WHO ARE WE? - HELP - BOOKSTORE
CONTACT T&C BY EMAIL OR WITH SKYPE Skype Me™!
SHOP LOCAL, ETHICAL AND AT THE BEST PRICE WITH Ethishop
 
 en español  en français  in italiano
translate in arabic chinese dutch german japanese korean russian

Home (12954 companies) > United States of America (2561 companies) > Pharmaceuticals (88 companies) >



Bristol Myers Squibb Co.


Headquarters location: 345 Park Avenue New York, NY 10154United States of AmericaTel. 212-546-4000 Job offers, investor relations: www.bms.com Stock: BMY


Bristol Myers Squibb belongs to

shareholder
country     %
source

Bristol Myers Squibb owns

subsidiary
country     %
source
Apothecon 100
ConvaTec United States of America100
Dermatology Direct 100
ImClone Systems Inc United States of America17Les Echos
Mead Johnson United States of America100
UPSA France100

Brands

name
items photo compare the prices
4-WayNasalSee the photo of: 4-WayNasalEthishop
AbilitySee the photo of: AbilityEthishop
Alpha KeriSee the photo of: Alpha KeriEthishop
AmmensSee the photo of: AmmensEthishop
BanSee the photo of: BanEthishop
Bristol Myers See the photo of: Bristol MyersEthishop
Bristol Myers SquibbSee the photo of: Bristol Myers SquibbEthishop
BufferinSee the photo of: BufferinEthishop
BuSparSee the photo of: BuSparEthishop
CardioliteSee the photo of: CardioliteEthishop
ComtrexSee the photo of: ComtrexEthishop
CoumadinSee the photo of: CoumadinEthishop
DuPont PharmaceuticalSee the photo of: DuPont PharmaceuticalEthishop
ElisorSee the photo of: ElisorEthishop
ExcedrinSee the photo of: ExcedrinEthishop
Fisherman’s FriendSee the photo of: Fisherman’s FriendEthishop
FostexSee the photo of: FostexEthishop
GlucophageSee the photo of: GlucophageEthishop
Herbal EssencesSee the photo of: Herbal EssencesEthishop
KeriSee the photo of: KeriEthishop
MoisturelSee the photo of: MoisturelEthishop
NoDozSee the photo of: NoDozEthishop
NuprinSee the photo of: NuprinEthishop
PlatinolSee the photo of: PlatinolEthishop
PreSunSee the photo of: PreSunEthishop
SaugellaSee the photo of: SaugellaEthishop
Sea BreezeSee the photo of: Sea BreezeEthishop
SquibbSee the photo of: SquibbEthishop
SustivaSee the photo of: SustivaEthishop
TaxolSee the photo of: TaxolEthishop
TempraSee the photo of: TempraEthishop
Therapeutic Mineral IceSee the photo of: Therapeutic Mineral IceEthishop
Vagistat-1See the photo of: Vagistat-1Ethishop
Shop local, ethical and at the best price on Ethishop !

« ETHICAL » RATING OF BRISTOL_MYERS_SQUIBB , group and subsidiaries [?]
14%
Job: 14% of company's jobs cut since 1998
1
Environment: 1 major pollution(s)
7
Delinquency: 7 act(s) of financial or trade delinquency
14
Tax haven, secret bank account, shell companies: operates in 14 offshore financial center(s)
19
Sales: more than 19 billion(s) dollars/euros in annual sales
27
Net profit: more than 27 billion(s) dollars/euros in cumulated net profit since 1998
1048
Top management: earns 1048 times the median income in the United States (32000 US$/year)
10
Influence: 10 act(s) of direct corruption or lobbying
2
Advertising & marketing: 2 dubious practice(s)

Relevance: business & market share

year
business
source
2006Bristol Myers Squibb is the world's thirteenth-largest pharmaceutical group.Les Echos

World locations & Manufacturing

country incentive : address & contact : production type
source
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Squibb Service Ltd :
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Grove Insurance Company Ltd :
Brazil 
Colombia 
Costa Rica Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Squibb de Costa Rica, S.A :
Dominica  Bristol-Myers Industrial inc. :
Guam Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Overseas Corporation :
Hong-Kong Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Squibb (Hong Kong) :
Cayman Islands Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Dalton Holdings Ltd. :
Cayman Islands Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Linson Investments Ltd :
United States Virgin Islands Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Foreign Sales Corporation :
Indonesia 
Iran 
Ireland Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Dublin : R&D Les Echos
Ireland Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Squibb Pharmaceuticals Ltd :
Lebanon Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Middle East S.A.L :
Mexico  DISTRITO FEDERAL ALVARO OBREGON REVOLUCION 1267 TLACOPAC & 5 2274800 :
Mexico  DISTRITO FEDERAL AZCAPOTZALCO PONIENTE 150 764 INDUSTRIAL VALLEJO & 7295400 :
Pakistan  Bristol-Myers Pakistan (Pvt.) :
Panama Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Squibb Middle East S.A :
Panama Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol Pharmaceutical Information Center, S.A :
Panama Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol Laboratories Products, Inc. :
Peru 
Philippines Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Dominican Republic Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Fray, S.A :
Singapore Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Squibb (Singapore) Pte. Ltd :
Switzerland Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Bristol-Myers Squibb (MEA) S.A :
Turkey 
Venezuela 

Bristol Myers Squibb is managed by

year name
photo position; compensation
source
2007Cornelius, James
See the photo of: Cornelius, James Chief Executive Officer;
2002Bonfield, Andrew
See the photo of: Bonfield, Andrew Chief Financial Officer; salary: 3.13 million US$;
2002Dolan, Peter
See the photo of: Dolan, Peter Chief Executive Officer; salary: 1.15 million US$;
2000Dolan, Peter
See the photo of: Dolan, Peter Chief Executive Officer; salary: 6.7 million US$;
1998Heimbold, Charles
See the photo of: Heimbold, Charles Chief Executive Officer; salary: 3.19 million US$; stock-options: 30.37 million US$;
1998Mee, Michael
See the photo of: Mee, Michael Vice-president;

Advertising & marketing

year
dubious practice : image
source
2004Arguable partnership: Don pour les victimes du tsunami: 1000000 de dollars: value: Humanitaire; AFP
2001ad budget: 485 million US$; Advertisin.
2000Disinformation: PR campaign with Ketchum PR: public relations: KPR Watch
2000ad budget: 424 million US$; Advertisin.

Made by

year
employees
<>
social impact : country
source
2007
-4300
Closure/Bankruptcy: Bristol Myers Squibb will cut its work force by 10 percent by 2010 and slash the number of its manufacturing plants by more than half, to generate an additional $1.5 billion in savings. Bristol Myers Squibb raised its 2008 earnings per share forecast, excluding special items, to $1.65 to $1.75 from a previous view of $1.60 to $1.70. That translates into an expectation of earnings growth next year of up to 19 percent.:
Reuters
2005
-41
Closure/Bankruptcy: Mise en vente de son centre de recherche et développement de Saint-Nazaire dans le cadre d'un regroupement de sa recherche. Si aucun repreneur ne se manifeste, cette unité sera fermée.:
Les Echos
2002
44000
2001
46000
2001
-1000
AP
2001
-2000
Les Echos
2001
-50
1999
54700

Environmental impact

year
country : consequences
source
2005brand: Ability : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA)New York T.
 United States of America : Carcinogenic silicone implants

Influence

year
purpose : intermediary/lobby : institution
source
2001Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government translateUSCIB
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington.
2000Investment protection and market access (to Mexico and Canada through NAFTA), to Latin America (through FTAA). : Business Roundtable : : US government, senate, congress translateCenter for.
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
2000Prevent binding regulation, co- or self-regulation instead. : American Chamber of Commerce's EU Committee : : European Commission translateCorporate .
1999Protection of Intellectual Property -TRIPS Agreement : Intellectual Property Committee : : WTO translateCorporate .
1999Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translateCorporate .
1998Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 212 thousand US$ : US President, Congress, Senate translateCenter for.
1997Legislation favorable to company's interests : Direct donation : amount: 3780 thousand US$ : US President, Congress, Senate translateCenter for.
1997Legislation favorable to company's interests : Direct donation : amount: 631 thousand US$ : US President, Congress, Senate translateCenter for.

Subsidy

yeardonatorcountryamountsource
1998EtatFrance1 million Eu€Les Echos

Financials

yearfinancial misdemeanorsalesincome buybacksource
2007   19.32.2   billion US$Les Echos
2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Bloomberg
2005 Agreed to pay $300 million in a deal to defer federal prosecution of a conspiracy charge stemming from an accounting scandal. Frederick Schiff, Bristol-Myers former chief financial officer, and Richard Lane, former executive vice president and president of the worldwide medicines group, were indicted on charges of conspiracy and securities fraud.     AP
2005 Has paid about $155,000 to New Mexico as the state's share in the settlement of an antitrust lawsuit; aaccused of overcharging health care services for the cancer-fighting drug Taxol and Children's Motrin     AP
2004   2.4   billion US$Les Echos
2004 Overstated profits from 1999 to 2002 by 700 millions US$     Chicago Tr.
2004 Agreed to pay $150 million to settle U.S. Securities and Exchange Commission allegations that it inflated sales by misusing discounts and incentives to drug wholesalers.     Bloomberg
2003   20.672.95   billion US$Les Echos
2003 Will pay about $670 million to settle allegations that it unlawfully delayed competition for its BuSpar anti-anxiety medication and Taxol cancer therapy.     Bloomberg
2002   18.122.07   billion US$
2002 SEC probe of sales practices: by offering incentives to wholesalers, BMS may have boosted revenue by as much as $1 billion.     CNN
2001   19.425.25   billion US$
2000   18.224.71   billion US$
1999   20.224.17   billion US$
1999   2billion US$SmartMoney
1998   18.283.14   billion US$
1998   2billion US$

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >


Further investigation
Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal
: present the company activities, improve the ethical rating's accuracy, develop an network of observers.
Name (or ninckname)*
Email
Title*
Link to document online
Information*
Alert me of answers by email * required field
Please copy the antispam code:


The 5 latest validated comments

Subscribe - Log in - Log out |
| © T&C 1999-2008